Document is current
Any future updates will be listed below
-
Authors
Wimmer, Isabella https://orcid.org/0000-0003-2231-2120
Tröscher, Anna R.
Brunner, Florian
Rubino, Stephen J.
Bien, Christian G.
Weiner, Howard L.
Lassmann, Hans
Bauer, Jan
- License Information
-
More Information
Article History
Received: 3 November 2017
Accepted: 10 April 2018
First Online: 20 April 2018
Change Date: 9 May 2018
Change Type: Update
Change Details: The HTML version of this Article previously published contained a grayscale version of Figure 4. This has now been corrected in the HTML version of the Article; the PDF version was correct at the time of publication.
Competing Interests
: C.G.B. gave scientific advice to Eisai (Frankfurt, Germany) and UCB (Monheim, Germany), undertook industry-funded travel with support of Eisai (Frankfurt, Germany), UCB (Monheim, Germany), Desitin (Hamburg, Germany), and Grifols (Frankfurt, Germany), and obtained honoraria for speaking engagements from Eisai (Frankfurt, Germany), UCB (Monheim, Germany), Desitin (Hamburg, Germany), Diamed (Köln, Germany), Fresenius Medical Care (Bad Homburg, Germany), Biogen (Ismaning, Germany) and Euroimmun (Lübeck, Germany). He received research support from Diamed (Köln, Germany) and Fresenius Medical Care (Bad Homburg, Germany). He is a consultant to the Laboratory Krone, Bad Salzuflen, Germany, regarding neural antibodies and therapeutic drug monitoring for antiepileptic drugs. H.L.W. reports grants from National Institutes of Health, National Multiple Sclerosis Society, Verily Life Sciences, Google Life Sciences, EMD Serono, Inc., Biogen, Teva Pharmaceuticals and Novartis; grants and consulting from Sanofi US Services, Inc. and Genentech, Inc.; consulting and advising from Tilos Therapeutics; consulting and advising from Tiziana Life Sciences; consulting and advising from IM Therapeutics; personal fees, consulting and advising from vTv Therapeutics; personal fees, consulting and advising from MedDay Pharmaceuticals. H.L. received honoraria for lectures from Novartis, Biogen and Sanofi Aventis. Moreover, he is a member of advisory boards at Roche and Medday. J.B. is a member of the scientific advisory board of the Dutch MS foundation “Stichting MS Research”. The other authors declare no competing financial or non-financial interests.
